Bayer Group - Investor-Relations

Five-Year Financial Summary
[Table 1.2]
2007 2008 2009 2010 2011
€ million € million € million € million € million
Bayer Group
Sales 32,385 32,918 31,168 35,088 36,528
Sales outside Germany 85.1% 85.4% 86.7% 87.4% 87.3%
EBIT (operating result) 3,154 3,544 3,006 2,730 4,149
EBIT before special items 1 4,287 4,342 3,772 4,452 5,025
EBITDA 1 5,866 6,266 5,815 6,286 6,918
EBITDA before special items 1 6,777 6,931 6,472 7,101 7,613
Income before income taxes 2,234 2,356 1,870 1,721 3,363
Income after taxes 4,716 1,724 1,359 1,310 2,472
Earnings per share (€) 2 5.84 2.22 1.70 1.57 2.99
Noncurrent assets 34,712 35,351 34,049 33,188 32,697
of which goodwill and other intangible assets 22,770 22,598 21,546 20,163 19,455
of which property, plant and equipment 8,819 9,492 9,409 9,835 9,823
Current assets 16,582 17,152 16,993 18,318 20,068
Inventories 6,217 6,681 6,091 6,104 6,368
Receivables and other current assets 7,834 8,377 8,177 9,374 11,846
Cash and cash equivalents 2,531 2,094 2,725 2,840 1,770
Financial liablities 14,417 16,870 12,949 11,833 11,679
Noncurrent 13,081 10,614 11,460 9,944 7,995
Current 1,336 6,256 1,489 1,889 3,684
Interest expense – net (701) (702) (548) (499) (335)
Return on equity 31.8% 10.4% 7.7% 6.9% 13.0%
Gross cash fl ow 3 4,784 5,295 4,658 4,771 5,172
Capital expenditures (total) 1,905 1,982 1,669 1,621 1,666
Depreciation and amortization 2,478 2,570 2,660 2,571 2,521
Personnel expenses
(including pension expenses) 7,571 7,491 7,776 8,099 8,726
Number of employees 4 (Dec. 31) 106,200 108,600 111,000 111,400 111,800
Research and development expenses
Equity including non-controlling interest
2,578 2,653 2,746 3,053 2,932
(total) 16,821 16,340 18,951 18,896 19,271
Capital stock 1,957 1,957 2,117 2,117 2,117
Reserves 14,864 14,383 16,834 16,779 17,154
Net income 4,711 1,719 1,359 1,301 2,470
Non-controlling interest 87 77 54 63 59
Liabilities (total) 34,557 36,171 32,091 32,610 33,494
Total assets 51,378 52,511 51,042 51,506 52,765
Equity ratio 32.7% 31.1% 37.1% 36.7% 36.5%
Bayer AG
Net income
Allocation to (withdrawal from) retained
1,928 1,161 2,226 1,245 1,134
earnings 896 91 1,068 5 (239)
Total dividend payment 1,032 1,070 1,158 1,240 1,364
Dividend per share (€) 1.35 1.40 1.40 1.50 1.65
1 For defi nition see Combined Management Report, Chapter 4.2 “Calculation of EBIT(DA) Before Special Items”.
2 Earnings per share: as defi ned in IAS 33: net income divided by the average number of shares. For details see Note [16] to the consolidated fi nancial statements.
3 For defi nition see Chapter 4.5 “Liquidity and Capital Expenditures of the Bayer Group”.
4 Full-time equivalents